Recent Activity

Activity stream for all registered members at Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales.

  1. CP Job Ratings posted a new thread.

    Merck - job rating

    Horrible culture read more... read more ratings or rate your company here

    Forum: Latest CP Job Ratings

    Oct 18, 2018 at 1:32 PM
  2. cafead posted a new thread.

    Novartis buys Endocyte for $2.1B in latest deal under CEO Narasimhan

    via Novartis will buy the Indiana-based biotech Endocyte and its experimental radiopharmaceutical drug for $2.1 billion, the Swiss...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 1:12 PM
  3. cafead posted a new thread.

    Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer...

    via Merck’s Keytruda knows how to make an entrance. On Thursday, it hit the scene with kidney cancer combination data that could snag it...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 1:12 PM
  4. cafead posted a new thread.

    Pfizer Confirms to Cut Workforce by 2%

    via Drugmaker Pfizer Inc. (PFE - Get Report) is looking to cut its total workforce of 90,000 "by a couple percentage points," TheStreet...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 12:52 PM
  5. cafead posted a new thread.

    Teva slumps after Express Scripts funds migraine rivals in US

    via A major prescription benefit manager in the US will not reimburse Teva’s preventative migraine drug Ajovy (fremanezumab), in an...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 11:42 AM
  6. cafead posted a new thread.

    Abbott CEO on Libre: ‘We’re just getting started’

    via The company’s diabetes revenues grew 37.5% to $512 million in Q3. Abbott touted a number of regulatory wins for its FreeStyle Libre...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 11:42 AM
  7. cafead posted a new thread.

    AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance

    via AbbVie is positioning itself to add fibrosis drugs to its pipeline through a new research and development partnership with startup...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 11:42 AM
  8. cafead posted a new thread.

    J&J takes $630M hit on RSV drug bought with Alios

    via Four years ago, Johnson & Johnson splashed out $1.75 billion to take control of antiviral specialist Alios, but the lead drug from...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 11:22 AM
  9. cafead posted a new thread.

    Gilead, Aelix ally to trial HIV-suppressing combination

    via Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 11:22 AM
  10. BAMABOY replied to the thread NCAA COLLEGE FOOTBALL PICK EM! WEEK 8! 2018.

    BAMABOY WEEK 8 PICKS: SATURDAY OCT. 20th: 1. MICHIGAN -7 VS. MICHIGAN STATE +7 2. AUBURN -4 VS. OLE MISS +4 3. OKLAHOMA -7 VS. TCU...

    Oct 18, 2018 at 10:54 AM
  11. BAMABOY liked tinkrbelle's post in the thread NCAA COLLEGE FOOTBALL PICK EM! WEEK 7! 2018.

    This was an exciting weekend of college football! I loved watching Auburn get beat, and some of the top teams losing. Meanwhile, my...

    Oct 18, 2018 at 10:51 AM
  12. cafead posted a new thread.

    Symberix Announces Non-Dilutive Funding Support for Lead Programs

    via Symberix announced on 10/18/18 has been awarded three Small Business Innovation Research (SBIR) grants from the National Institutes...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 12:42 AM
  13. cafead posted a new thread.

    LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity

    via LNC Therapeutics announced on 10/15/18 that it has signed an exclusive license agreement with Cornell University (Ithaca, NY, USA)...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 12:42 AM
  14. cafead posted a new thread.

    New eye health companies gain funders’ focus

    via Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 12:42 AM
  15. cafead posted a new thread.

    Can Pfizer's new breast cancer drug Talzenna really make a dent in the PARP field?

    via The FDA approved Pfizer's PARP inhibitor, Talzenna, to treat breast cancer, but as the fourth-to-market drug in that class, it's...

    Forum: Pharma/Biotech Companies - In the News

    Oct 18, 2018 at 12:22 AM
Loading...